Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines
Authors:
Open Access
- 31 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 220 (Supplement) , S274-S278
Abstract
The introduction and rollout of a meningococcal serogroup A conjugate vaccine, MenAfriVac, in the African meningitis belt has eliminated serogroup A meningococcal infections for >300 million Africans. However, serogroup C, W, and X meningococci continue to circulate and have been responsible for focal epidemics in meningitis belt countries. Affordable multivalent meningococcal conjugate vaccines are being developed to prevent these non-A epidemics. This article describes the current epidemiologic situation and status of vaccine development and highlights questions to be addressed to most efficiently use these new vaccines.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1112245)
This publication has 18 references indexed in Scilit:
- Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013Clinical Infectious Diseases, 2015
- The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate VaccineThe Journal of Infectious Diseases, 2015
- Meningococcal A conjugate vaccine: updated guidance, February 2015.2015
- Process development and immunogenicity studies on a serogroup ‘X’ Meningococcal polysaccharide conjugate vaccineBiologicals, 2014
- Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community studyThe Lancet, 2014
- Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd ImmunityClinical Infectious Diseases, 2012
- Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance dataThe Lancet Infectious Diseases, 2012
- Costs and impact of meningitis epidemics for the public health system in Burkina FasoVaccine, 2011
- Costs for Households and Community Perception of Meningitis Epidemics in Burkina FasoClinical Infectious Diseases, 2009
- Meningococcal meningitis in AfricaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999